PWMG
CRL icon

Prestige Wealth Management Group’s Charles River Laboratories CRL Stock Holding History

Prestige Wealth Management Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.58K Hold
29
– – ﹤0.01% 516
2026
Q1 		$5K Hold
29
– – ﹤0.01% 559
2025
Q4 		$5.79K Hold
29
– – ﹤0.01% 539
2025
Q3 		$4.54K Buy
29
+10
+53% +$1.59K ﹤0.01% 585
2025
Q2 		$2.88K Sell
19
-2
-10% -$267 ﹤0.01% 671
2025
Q1 		$3.16K Sell
21
-5
-19% -$838 ﹤0.01% 650
2024
Q4 		$4.8K Hold
26
– – ﹤0.01% 613
2024
Q3 		$5.12K Buy
26
+7
+37% +$1.46K ﹤0.01% 610
2024
Q2 		$3.93K Hold
19
– – ﹤0.01% 598
2024
Q1 		$5.15K Hold
19
– – ﹤0.01% 563
2023
Q4 		$4.49K Hold
19
– – ﹤0.01% 608
2023
Q3 		$3.72K Hold
19
– – ﹤0.01% 633
2023
Q2 		$4K Hold
19
– – ﹤0.01% 645
2023
Q1 		$3.83K Hold
19
– – ﹤0.01% 639
2022
Q4 		$4.14K Hold
19
– – ﹤0.01% 662
2022
Q3 		$4K Sell
19
-4
-17% -$864 ﹤0.01% 584
2022
Q2 		$5K Buy
23
+4
+21% +$977 ﹤0.01% 570
2022
Q1 		$5K Hold
19
– – ﹤0.01% 596
2021
Q4 		$7K Hold
19
– – ﹤0.01% 547
2021
Q3 		$8K Hold
19
– – ﹤0.01% 524
2021
Q2 		$7K Hold
19
– – ﹤0.01% 547
2021
Q1 		$6K Hold
19
– – ﹤0.01% 573
2020
Q4 		$5K Hold
19
– – ﹤0.01% 569
2020
Q3 		$4K Hold
19
– – ﹤0.01% 560
2020
Q2 		$3K Hold
19
– – ﹤0.01% 594
2020
Q1 		$2K Buy
+19
New +$2.85K ﹤0.01% 619
2019
Q1 		– Sell
-36
Closed -$4K – 634
2018
Q4 		$4K Buy
+36
New +$4.51K ﹤0.01% 629

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Prestige Wealth Management Group's CRL Position: Q2 2026 in Review

Prestige Wealth Management Group held its Charles River Laboratories (CRL) position steady in Q2 2026 at 29 shares worth $6.58K. The position accounts for ﹤0.01% of the portfolio, ranked #516.

Prestige Wealth Management Group first reported a position in CRL in Q4 2018 and has held it in 27 quarters since. The position peaked at $8K in Q3 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Prestige Wealth Management Group held 29 shares of Charles River Laboratories worth $6.58K as of Q2 2026.
  • Prestige Wealth Management Group left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #516 holding.
  • Prestige Wealth Management Group first reported a position in Charles River Laboratories in Q4 2018 and has held it in 27 quarters since.
  • Prestige Wealth Management Group's Charles River Laboratories position peaked at $8K in Q3 2021.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.